Clinical trial
A Study of Octreotide Depot vs Saline Control in Pediatric Hypothalamic Obesity…
NCT00171613 · Novartis, Industry · Completed
Key facts
| NCT number | NCT00171613 |
|---|---|
| Title | A Study of Octreotide Depot vs Saline Control in Pediatric Hypothalamic Obesity Patients |
| Official title | A Study of Octreotide Depot vs Saline Control in Pediatric Hypothalamic Obesity Patients |
| Lead sponsor | Novartis, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Hypothalamic Obesity |
| Intervention type | Drug |
| Interventions | Octreotide |
| Enrollment | 32 |
| Start date | Feb 1, 2005 |
| Primary completion | Oct 1, 2005 |
| First posted | Sep 15, 2005 |
| Last update posted | Apr 30, 2012 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: